The 12th Asia Pharma R&D Leaders 2023
Time：August 24th-25th, 2023
Address：Shanghai · China
Theme：Patient-Centered Innovation-Enabled Clinical
At present,China's innovative drug research and development is showing a vigorous growth trend, andthe gap between China's new drug R&D and the world is gradually narrowing, but with more playersentering the market, competition is becoming more intense. Currently, the domestic market is no longeiwell capitalized, targets are full, and more competition under pressure to enter health insurance. At thesame time, the continuous progress of drug development and changing regulatory approval requirements in the internationa market have put forward hicher reguirements for domestic pharmaceuticacompanies' innovative drug development capabilities, clinical trial desian capabilities, domesticand international clinical trial promotion capabilities, and communication capabilities with regulatoryauthorities. In the current situation of intensified competition, returning to the origin of innovationand promoting differentiated innovation oriented to clinical value has become the main theme oChina's pharmaceuticalindustrv developmentBased on this The 12th Asia Pharma R&D Leaders 2023, themed 'Patient-Centered, Innovation-Enabled Clinical' will be held again in Shanghai on August 24-25, 2023, and wil again bringtogether 90+ pharmaceutical R&D leaders and 1000+ industry colleaaues on the basis of the succes.of the previous 11 conferences, deeply explore differentiated R&D strategies, strive to improve clinicadevelopment efficiency, promote the internationalization of innovative drug R8D, patient-centeredand return to the origin of innovation, and to make innovation truly empowering to the clinic!